欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/0722/001
药品名称Xeomin
活性成分
    • Clostridium botulinum type A neurotoxin complex 100.0 LD50 units
剂型Powder for solution for injection
上市许可持有人Merz Pharmaceuticals GmbH Eckenheimer Landstr. 100 60318 Frankfurt am Main Germany
参考成员国 - 产品名称Germany (DE)
Xeomin
互认成员国 - 产品名称
    • Denmark (DK)
      Xeomin
    • Luxembourg (LU)
    • Austria (AT)
      Xeomin 100 LD50-Einheiten Pulver zur Herstellung einer Injektionslösung
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
      Xeomin
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Xeomin
    • Belgium (BE)
      Xeomeen 50 / 100 / 200 unités poudre pour solution injectable
    • Netherlands (NL)
    • Iceland (IS)
    • Ireland (IE)
    • Liechtenstein (LI)
    • Greece (GR)
      XEOMIN
    • Latvia (LV)
      Xeomin 100 V pulveris injekciju šķīduma pagatavošanai
    • Lithuania (LT)
      XEOMIN 50 V milteliai injekciniam tirpalui
    • Estonia (EE)
      XEOMIN
    • Hungary (HU)
      XEOMIN 100 LD50-egység por oldatos injekcióhoz
    • Bulgaria (BG)
      Xeomin
    • Cyprus (CY)
      XEOMIN PWD FOR SOL FOR INJ 50LD
    • Czechia (CZ)
      XEOMIN
    • Malta (MT)
      XEOMIN 100 LD50 units powder for solution for injection
    • Romania (RO)
      XEOMIN 50 unităţi pulbere pentru soluţie injectabilă
    • Slovenia (SI)
    • Slovakia (SK)
    • Croatia (HR)
许可日期2007/10/24
最近更新日期2024/11/26
药物ATC编码
    • M03AX01 botulinum toxin
申请类型
  • TypeLevel1：New Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase